Thame, United Kingdom · Founded 2022 · Privately Held (backing)
Developer of a PCR testing platform designed to make precision diagnostics accessible to all. Signatur Biosciences is based in Thame, United Kingdom and was founded in 2022. Its last reported valuation was $7.1 million in Jan 2022. It has raised $7.5 million.
Last reported valuation
$7.1M
Oct 2026
Priced at
—
Total raised
$7.5M
Last round
—
Cap table — not yet on record
Signatur Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Signatur Biosciences with a free Private Market View account
·Watch Signatur Biosciences: the Monday email on marks, rounds and moves
